Association of the alternative pathway of complement activation with incident cardiovascular diseases: the CODAM study

被引:0
|
作者
Hertle, E. [1 ,2 ]
Arts, I. C. W. [1 ,3 ,4 ]
van der Kallen, C. J. H. [1 ,2 ]
Feskens, E. J. M. [5 ]
Schalkwijk, C. G. [1 ,2 ]
Stehouwer, C. D. A. [1 ,2 ]
van Greevenbroek, M. M. J. [1 ,2 ]
机构
[1] Maastricht Univ, Med Ctr, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands
[3] Maastricht Univ, Med Ctr, Dept Epidemiol, Maastricht, Netherlands
[4] Maastricht Univ, Med Ctr, Sch Publ Hlth & Primary Care CAPHRI, Maastricht, Netherlands
[5] Wageningen Univ, Sect Nutr & Epidemiol, Div Human Nutr, NL-6700 AP Wageningen, Netherlands
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1234
引用
收藏
页码:S502 / S502
页数:1
相关论文
共 50 条
  • [1] Association of the alternative pathway of complement activation with incident cardiovascular diseases: the CODAM study
    Hertle, Elisabeth
    Arts, Ilja C. W.
    van der Kallen, Carla J. H.
    Feskens, Edith J. M.
    Schalkwijk, Casper G.
    Stehouwer, Coen D. A.
    van Greevenbroek, Marleen M. J.
    MOLECULAR IMMUNOLOGY, 2014, 61 (02) : 228 - 228
  • [2] Associations of the alternative pathway and classical pathway of complement activation with incident metabolic syndrome: The CODAM study
    Xin, Ying
    Hertle, Elisabeth
    van der Kallen, Carla J. H.
    Schalkwijk, Casper G.
    Stehouwer, Coen D. A.
    van Greevenbroek, Marleen M. J.
    MOLECULAR IMMUNOLOGY, 2017, 89 : 190 - 190
  • [3] The alternative pathway of complement activation is longitudinally associated with obesity: the CODAM study
    Xin, Y.
    Hertle, E.
    van der Kallen, C.
    Schalkwijk, C.
    Stehouwer, C.
    van Greevenbroek, M.
    DIABETOLOGIA, 2016, 59 : S293 - S294
  • [4] The alternative complement pathway is longitudinally associated with adverse cardiovascular outcomes The CODAM study
    Hertle, Elisabeth
    Arts, Ilja C. W.
    van der Kallen, Carla J. H.
    Feskens, Edith J. M.
    Schalkwijk, Casper G.
    Stehouwer, Coen D. A.
    van Greevenbroek, Marleen M. J.
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (02) : 446 - 457
  • [5] ASSOCIATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT ACTIVATION WITH INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND CAROTID INTIMA-MEDIA THICKNESS: THE CODAM STUDY
    Hertle, E.
    Arts, I. C. W.
    van der Kallen, C. J. H.
    Feskens, E. J. M.
    Schalkwijk, C. G.
    Stehouwer, C. D. A.
    van Greevenbroek, M. M. J.
    ATHEROSCLEROSIS, 2015, 241 (01) : E67 - E67
  • [6] THE ALTERNATIVE COMPLEMENT PATHWAY IS ASSOCIATED WITH AN ADVERSE LIPID PROFILE: THE CODAM STUDY
    Xin, Y.
    van der Kallen, C. J. H.
    Schalkwijk, C. G.
    Stehouwer, C. D. A.
    van Greevenbroek, M. M. J.
    ATHEROSCLEROSIS, 2019, 287 : E30 - E31
  • [7] The alternative complement pathway is associated with an adverse lipid profile: the CODAM study
    Jin, S.
    Xin, Y.
    van der Kallen, C.
    Vogelzangs, N.
    Arts, I.
    Schalkwijk, C.
    Stehouwer, C.
    van Greevenbroek, M.
    DIABETOLOGIA, 2019, 62 : S294 - S294
  • [8] Longitudinal associations of the alternative and terminal pathways of complement activation with adiposity: The CODAM study
    Xin, Ying
    Hertle, Elisabeth
    van der Kallen, Carla J. H.
    Schalkwijk, Casper G.
    Stehouwer, Coen D. A.
    van Greevenbroek, Marleen M. J.
    OBESITY RESEARCH & CLINICAL PRACTICE, 2018, 12 (03) : 286 - 292
  • [9] The role of the alternative pathway of complement activation in glomerular diseases
    Emilia Łukawska
    Magdalena Polcyn-Adamczak
    Zofia I. Niemir
    Clinical and Experimental Medicine, 2018, 18 : 297 - 318
  • [10] The role of the alternative pathway of complement activation in glomerular diseases
    Lukawska, Emilia
    Polcyn-Adamczak, Magdalena
    Niemir, Zofia I.
    CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 18 (03) : 297 - 318